Morgan Stanley Kura Oncology, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,206,714 shares of KURA stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,206,714

Previous 1,328,514 9.17%

Holding current value

$13 Million

Previous $27.4 Million 13.8%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.57 - $23.23 $2.26 Million - $2.83 Million	-121,800 Reduced 9.17%	1,206,714 $23.6 Million
Q2 2024 Oct 17, 2024	SELL	$17.53 - $22.98 $507,440 - $665,202	-28,947 Reduced 2.13%	1,328,514 $27.4 Million
Q2 2024 Aug 14, 2024	SELL	$17.53 - $22.98 $507,440 - $665,202	-28,947 Reduced 2.13%	1,328,514 $27.4 Million
Q1 2024 Oct 17, 2024	BUY	$13.42 - $23.53 $388,468 - $681,122	28,947 Added 2.18%	1,357,461 $29 Million
Q1 2024 Aug 16, 2024	BUY	$13.42 - $23.53 $355,710 - $623,686	26,506 Added 1.99%	1,357,461 $29 Million
Q1 2024 May 15, 2024	BUY	$13.42 - $23.53 $355,710 - $623,686	26,506 Added 1.99%	1,357,461 $29 Million
Q4 2023 Aug 16, 2024	BUY	$7.58 - $14.38 $18,502 - $35,101	2,441 Added 0.18%	1,330,955 $19.1 Million
Q4 2023 Feb 13, 2024	BUY	$7.58 - $14.38 $8.87 Million - $16.8 Million	1,169,992 Added 726.87%	1,330,955 $19.1 Million
Q3 2023 Nov 15, 2023	SELL	$8.44 - $11.86 $1.07 Million - $1.5 Million	-126,764 Reduced 44.06%	160,963 $1.47 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $737,671 - $1.07 Million	76,681 Added 36.33%	287,727 $3.04 Million
Q1 2023 May 15, 2023	SELL	$10.71 - $14.6 $693,429 - $945,291	-64,746 Reduced 23.48%	211,046 $2.58 Million
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $1.29 Million - $1.94 Million	-114,716 Reduced 29.38%	275,792 $3.42 Million
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $3.67 Million - $5.94 Million	-305,292 Reduced 43.88%	390,508 $5.33 Million
Q2 2022 Oct 27, 2022	BUY	$10.71 - $18.33 $2.69 Million - $4.6 Million	250,960 Added 56.42%	695,800 $12.8 Million
Q2 2022 Aug 15, 2022	BUY	$10.71 - $18.33 $2.69 Million - $4.6 Million	250,960 Added 56.42%	695,800 $12.8 Million
Q1 2022 Oct 27, 2022	SELL	$11.78 - $16.98 $2.96 Million - $4.26 Million	-250,960 Reduced 36.07%	444,840 $7.15 Million
Q1 2022 May 13, 2022	BUY	$11.78 - $16.98 $4.26 Million - $6.14 Million	361,551 Added 434.09%	444,840 $7.15 Million
Q4 2021 Feb 14, 2022	SELL	$12.22 - $19.57 $949,958 - $1.52 Million	-77,738 Reduced 48.28%	83,289 $1.17 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $2.48 Million - $3.5 Million	161,027 New	161,027 $3.02 Million

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $722M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account